{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,24]],"date-time":"2026-08-24T17:37:55Z","timestamp":1787593075477,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T00:00:00Z","timestamp":1769126400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T00:00:00Z","timestamp":1774569600000},"content-version":"vor","delay-in-days":63,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Geriatr"],"DOI":"10.1186\/s12877-026-06972-3","type":"journal-article","created":{"date-parts":[[2026,1,23]],"date-time":"2026-01-23T01:41:56Z","timestamp":1769132516000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Healthcare professionals\u2019 perspectives on prescribing DOACs to frail older patients; the DOAC-FRAIL questionnaire"],"prefix":"10.1186","volume":"26","author":[{"given":"M.J.","family":"de Jong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A. D.H.","family":"Brys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.","family":"Braeken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Pisters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D. J.A.","family":"Janssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Altintas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S. H.M.","family":"Robben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Nicola\u00ef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Eurlings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A.","family":"Zwietering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"De Jonghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B.","family":"Vaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"De Backer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Grymonprez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"Joosten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H.","family":"ten Cate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K.","family":"Winckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F. J.H.","family":"Magdelijns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,1,23]]},"reference":[{"issue":"12","key":"6972_CR1","doi-asserted-by":"publisher","first-page":"e2137288","DOI":"10.1001\/jamanetworkopen.2021.37288","volume":"4","author":"KM Wheelock","year":"2021","unstructured":"Wheelock KM, Ross JS, Murugiah K, Lin Z, Krumholz HM, Khera R. Clinician trends in prescribing direct oral anticoagulants for US medicare beneficiaries. JAMA Netw Open. 2021;4(12):e2137288.","journal-title":"JAMA Netw Open"},{"issue":"6","key":"6972_CR2","doi-asserted-by":"publisher","first-page":"102544","DOI":"10.1016\/j.rpth.2024.102544","volume":"8","author":"TAC de Vries","year":"2024","unstructured":"de Vries TAC, Bavalia R, Chu G, Xiong H, van de Wiel KM, van Ballegooijen H, et al. Prescription and switching patterns of direct oral anticoagulants in patients with atrial fibrillation. Res Pract Thromb Haemostasis. 2024;8(6):102544.","journal-title":"Res Pract Thromb Haemostasis"},{"key":"6972_CR3","doi-asserted-by":"publisher","first-page":"907197","DOI":"10.3389\/fcvm.2022.907197","volume":"9","author":"S Zeng","year":"2022","unstructured":"Zeng S, Zheng Y, Jiang J, Ma J, Zhu W, Cai X. Effectiveness and safety of DOACs vs. Warfarin in patients with atrial fibrillation and frailty: A systematic review and Meta-Analysis. Front Cardiovasc Med. 2022;9:907197.","journal-title":"Front Cardiovasc Med"},{"key":"6972_CR4","doi-asserted-by":"publisher","unstructured":"Ferri N, Colombo E, Tenconi M, Baldessin L, Corsini A. Drug-drug interactions of direct oral Anticoagulants (DOACs): From Pharmacological to Clinical Practice. Pharmaceutics. 2022;14(6):1120. PMID: 35745692; PMCID:\u00a0PMC9229376.\u00a0https:\/\/doi.org\/10.3390\/pharmaceutics14061120.","DOI":"10.3390\/pharmaceutics14061120"},{"issue":"4","key":"6972_CR5","first-page":"279","volume":"149","author":"LPT Joosten","year":"2024","unstructured":"Joosten LPT, van Doorn S, van de Ven PM, K\u00f6hlen BTG, Nierman MC, Koek HL, et al. Safety of switching from a vitamin K antagonist to a Non-Vitamin K antagonist oral anticoagulant in frail older patients with atrial fibrillation: results of the FRAIL-AF randomized controlled trial. Circulation. 2024;149(4):279\u201389.","journal-title":"Circulation"},{"issue":"7","key":"6972_CR6","doi-asserted-by":"publisher","first-page":"2249","DOI":"10.1111\/jgs.18894","volume":"72","author":"MJ de Jong","year":"2024","unstructured":"de Jong MJ, Saadan H, Hellenbrand DLS, Ten Cate H, Spaetgens B, Br\u00fcggemann RAG, et al. The DOAC-FRAIL study, evaluation of direct oral anticoagulant-levels in acutely admitted frail older patients: an exploratory study. J Am Geriatr Soc. 2024;72(7):2249\u201353.","journal-title":"J Am Geriatr Soc"},{"issue":"12","key":"6972_CR7","doi-asserted-by":"publisher","first-page":"105280","DOI":"10.1016\/j.jamda.2024.105280","volume":"25","author":"MJ de Jong","year":"2024","unstructured":"de Jong MJ, Saadan H, van der Hooft BHM, Hellenbrand DLS, Br\u00fcggemann RAG, Ten Cate H, et al. Intra-Individual variability of direct oral anticoagulant levels in frail older patients upon, during, and after acute hospitalization: the DOAC-FRAIL study. J Am Med Dir Assoc. 2024;25(12):105280.","journal-title":"J Am Med Dir Assoc"},{"issue":"1","key":"6972_CR8","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1111\/jth.15563","volume":"20","author":"MMA Toorop","year":"2022","unstructured":"Toorop MMA, van Rein N, Nierman MC, Vermaas HW, Huisman MV, van der Meer FJM, et al. Inter- and intra-individual concentrations of direct oral anticoagulants: the KIDOAC study. J Thromb Haemost. 2022;20(1):92\u2013103.","journal-title":"J Thromb Haemost"},{"key":"6972_CR9","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1016\/j.thromres.2015.12.001","volume":"137","author":"S Testa","year":"2016","unstructured":"Testa S, Tripodi A, Legnani C, Pengo V, Abbate R, Dellanoce C, et al. Plasma levels of direct oral anticoagulants in real life patients with atrial fibrillation: results observed in four anticoagulation clinics. Thromb Res. 2016;137:178\u201383.","journal-title":"Thromb Res"},{"issue":"10","key":"6972_CR10","doi-asserted-by":"publisher","first-page":"1612","DOI":"10.1093\/europace\/euab065","volume":"23","author":"J Steffel","year":"2021","unstructured":"Steffel J, Collins R, Antz M, Cornu P, Desteghe L, Haeusler KG, et al. 2021 European heart rhythm association practical guide on the use of Non-Vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Europace. 2021;23(10):1612\u201376.","journal-title":"Europace"},{"issue":"36","key":"6972_CR11","doi-asserted-by":"publisher","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","volume":"45","author":"IC Van Gelder","year":"2024","unstructured":"Van Gelder IC, Rienstra M, Bunting KV, Casado-Arroyo R, Caso V, Crijns H, et al. 2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS). Eur Heart J. 2024;45(36):3314\u2013414.","journal-title":"Eur Heart J"},{"issue":"5","key":"6972_CR12","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1093\/eurheartj\/ehaa612","volume":"42","author":"G Hindricks","year":"2021","unstructured":"Hindricks G, Potpara T, Dagres N, Arbelo E, Bax JJ, Blomstr\u00f6m-Lundqvist C, et al. 2020 ESC guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European association for Cardio-Thoracic surgery (EACTS): the task force for the diagnosis and management of atrial fibrillation of the European society of cardiology (ESC) developed with the special contribution of the European heart rhythm association (EHRA) of the ESC. Eur Heart J. 2021;42(5):373\u2013498.","journal-title":"Eur Heart J"},{"issue":"5","key":"6972_CR13","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1503\/cmaj.050051","volume":"173","author":"K Rockwood","year":"2005","unstructured":"Rockwood K, Song X, MacKnight C, Bergman H, Hogan DB, McDowell I, et al. A global clinical measure of fitness and frailty in elderly people. CMAJ. 2005;173(5):489\u201395.","journal-title":"CMAJ"},{"issue":"16","key":"6972_CR14","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1093\/eurheartj\/ehy136","volume":"39","author":"J Steffel","year":"2018","unstructured":"Steffel J, Verhamme P, Potpara TS, Albaladejo P, Antz M, Desteghe L, et al. The 2018 European heart rhythm association practical guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Eur Heart J. 2018;39(16):1330\u201393.","journal-title":"Eur Heart J"},{"key":"6972_CR15","unstructured":"Informatie BCvF. Gecommentarieerd Geneesmiddelenrepertorium; DOACs 2025 [updated 18-11-2025. Available from: https:\/\/www.bcfi.be\/nl\/chapters\/3?frag=25890"},{"issue":"10","key":"6972_CR16","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1002\/phar.1989","volume":"37","author":"BS Manzoor","year":"2017","unstructured":"Manzoor BS, Lee TA, Sharp LK, Walton SM, Galanter WL, Nutescu EA. Real-World adherence and persistence with direct oral anticoagulants in adults with atrial fibrillation. Pharmacotherapy. 2017;37(10):1221\u201330.","journal-title":"Pharmacotherapy"},{"issue":"6","key":"6972_CR17","doi-asserted-by":"publisher","first-page":"1254","DOI":"10.1111\/bcp.12732","volume":"80","author":"E Reeve","year":"2015","unstructured":"Reeve E, Gnjidic D, Long J, Hilmer S. A systematic review of the emerging definition of \u2018deprescribing\u2019 with network analysis: implications for future research and clinical practice. Br J Clin Pharmacol. 2015;80(6):1254\u201368.","journal-title":"Br J Clin Pharmacol"},{"issue":"3","key":"6972_CR18","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1055\/s-0038-1627480","volume":"118","author":"RC Gosselin","year":"2018","unstructured":"Gosselin RC, Adcock DM, Bates SM, Douxfils J, Favaloro EJ, Gouin-Thibault I, et al. International Council for standardization in haematology (ICSH) recommendations for laboratory measurement of direct oral anticoagulants. Thromb Haemost. 2018;118(3):437\u201350.","journal-title":"Thromb Haemost"},{"key":"6972_CR19","unstructured":"NIV NIV. Antitrombotisch beleid: Federatie Medisch Specialisten. 2025 [updated 22-10-2025. Available from: https:\/\/richtlijnendatabase.nl\/richtlijn\/antitrombotisch_beleid\/startpagina_-_antitrombotisch_beleid.html"},{"issue":"2","key":"6972_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1111\/jth.13912","volume":"16","author":"J Douxfils","year":"2018","unstructured":"Douxfils J, Ageno W, Samama CM, Lessire S, Ten Cate H, Verhamme P, et al. Laboratory testing in patients treated with direct oral anticoagulants: a practical guide for clinicians. J Thromb Haemost. 2018;16(2):209\u201319.","journal-title":"J Thromb Haemost"},{"issue":"6","key":"6972_CR21","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/ajh.25475","volume":"94","author":"A Cuker","year":"2019","unstructured":"Cuker A, Burnett A, Triller D, Crowther M, Ansell J, Van Cott EM, et al. Reversal of direct oral anticoagulants: guidance from the anticoagulation forum. Am J Hematol. 2019;94(6):697\u2013709.","journal-title":"Am J Hematol"},{"key":"6972_CR22","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.thromres.2019.01.016","volume":"175","author":"A Winther-Larsen","year":"2019","unstructured":"Winther-Larsen A, Hvas AM. Clinical impact of direct oral anticoagulant measuring in a real-life setting. Thromb Res. 2019;175:40\u20135.","journal-title":"Thromb Res"},{"issue":"9","key":"6972_CR23","doi-asserted-by":"publisher","first-page":"1807","DOI":"10.1111\/j.1532-5415.2010.03043.x","volume":"58","author":"RT Koopmans","year":"2010","unstructured":"Koopmans RT, Lavrijsen JC, Hoek JF, Went PB, Schols JM. Dutch elderly care physician: a new generation of nursing home physician specialists. J Am Geriatr Soc. 2010;58(9):1807\u20139.","journal-title":"J Am Geriatr Soc"},{"key":"6972_CR24","unstructured":"Likert R. A technique for the measurement of attitudes. Archives Psychol. 1932."},{"issue":"13","key":"6972_CR25","doi-asserted-by":"publisher","first-page":"e017559","DOI":"10.1161\/JAHA.120.017559","volume":"9","author":"A Chen","year":"2020","unstructured":"Chen A, Stecker E. Direct oral anticoagulant use: A practical guide to common clinical challenges. J Am Heart Assoc. 2020;9(13):e017559.","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"6972_CR26","doi-asserted-by":"publisher","first-page":"3920","DOI":"10.1016\/j.sapharm.2022.06.002","volume":"18","author":"S Salmasi","year":"2022","unstructured":"Salmasi S, Safari A, Kapanen A, Adelakun A, Kwan L, MacGillivray J, et al. Oral anticoagulant adherence and switching in patients with atrial fibrillation: A prospective observational study. Res Social Adm Pharm. 2022;18(11):3920\u20138.","journal-title":"Res Social Adm Pharm"},{"issue":"5","key":"6972_CR27","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1007\/s10557-019-06907-8","volume":"33","author":"RE Harskamp","year":"2019","unstructured":"Harskamp RE, Teichert M, Lucassen WAM, van Weert H, Lopes RD. Impact of polypharmacy and P-Glycoprotein- and CYP3A4-Modulating drugs on safety and efficacy of oral anticoagulation therapy in patients with atrial fibrillation. Cardiovasc Drugs Ther. 2019;33(5):615\u201323.","journal-title":"Cardiovasc Drugs Ther"},{"issue":"1","key":"6972_CR28","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1097\/MJT.0000000000001083","volume":"28","author":"M Kajy","year":"2021","unstructured":"Kajy M, Mathew A, Ramappa P. Treatment failures of direct oral anticoagulants. Am J Ther. 2021;28(1):e87\u201395.","journal-title":"Am J Ther"},{"issue":"10","key":"6972_CR29","doi-asserted-by":"publisher","first-page":"4264","DOI":"10.1007\/s12325-023-02544-8","volume":"40","author":"K Hahn","year":"2023","unstructured":"Hahn K, Lamparter M. Prescription of DOACs in patients with atrial fibrillation at different stages of renal insufficiency. Adv Ther. 2023;40(10):4264\u201381.","journal-title":"Adv Ther"},{"issue":"9","key":"6972_CR30","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.7326\/M20-7141","volume":"174","author":"DH Kim","year":"2021","unstructured":"Kim DH, Pawar A, Gagne JJ, Bessette LG, Lee H, Glynn RJ, et al. Frailty and clinical outcomes of direct oral anticoagulants versus warfarin in older adults with atrial fibrillation: A cohort study. Ann Intern Med. 2021;174(9):1214\u201323.","journal-title":"Ann Intern Med"},{"key":"6972_CR31","doi-asserted-by":"crossref","unstructured":"Hayes KN, Zhang T, Kim DH, Daiello LA, Lee Y, Kiel DP, et al. Benefits and Harms of Standard Versus Reduced\u2010Dose Direct Oral Anticoagulant Therapy for Older Adults With Multiple Morbidities and Atrial Fibrillation. Journal of the American Heart Association. 2023;12(21):e029865.","DOI":"10.1161\/JAHA.122.029865"},{"key":"6972_CR32","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1016\/j.thromres.2023.01.030","volume":"225","author":"A Tripodi","year":"2023","unstructured":"Tripodi A, Chantarangkul V, Poli D, Testa S, Bucciarelli P, Peyvandi F. The role of anticoagulation clinics needs to be reassessed to include follow up of patients on direct oral anticoagulants. Thromb Res. 2023;225:11\u20135.","journal-title":"Thromb Res"},{"issue":"3","key":"6972_CR33","doi-asserted-by":"publisher","first-page":"e12696","DOI":"10.1002\/rth2.12696","volume":"6","author":"KW Sylvester","year":"2022","unstructured":"Sylvester KW, Chen A, Lewin A, Fanikos J, Goldhaber SZ, Connors JM. Optimization of DOAC management services in a centralized anticoagulation clinic. Res Pract Thromb Haemost. 2022;6(3):e12696.","journal-title":"Res Pract Thromb Haemost"},{"issue":"6","key":"6972_CR34","doi-asserted-by":"publisher","first-page":"3019","DOI":"10.1016\/j.sapharm.2021.07.027","volume":"18","author":"V Albert","year":"2022","unstructured":"Albert V, Baumgartner PC, Hersberger KE, Arnet I. How do elderly outpatients manage polypharmacy including DOAC - A qualitative analysis highlighting a need for counselling. Res Social Adm Pharm. 2022;18(6):3019\u201326.","journal-title":"Res Social Adm Pharm"},{"issue":"4","key":"6972_CR35","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jacc.2013.07.104","volume":"63","author":"PA Reilly","year":"2014","unstructured":"Reilly PA, Lehr T, Haertter S, Connolly SJ, Yusuf S, Eikelboom JW, et al. The effect of Dabigatran plasma concentrations and patient characteristics on the frequency of ischemic stroke and major bleeding in atrial fibrillation patients: the RE-LY trial (Randomized evaluation of Long-Term anticoagulation Therapy). J Am Coll Cardiol. 2014;63(4):321\u20138.","journal-title":"J Am Coll Cardiol"},{"issue":"9984","key":"6972_CR36","doi-asserted-by":"publisher","first-page":"2288","DOI":"10.1016\/S0140-6736(14)61943-7","volume":"385","author":"CT Ruff","year":"2015","unstructured":"Ruff CT, Giugliano RP, Braunwald E, Morrow DA, Murphy SA, Kuder JF, et al. Association between Edoxaban dose, concentration, anti-Factor Xa activity, and outcomes: an analysis of data from the randomised, double-blind ENGAGE AF-TIMI 48 trial. Lancet. 2015;385(9984):2288\u201395.","journal-title":"Lancet"},{"issue":"5","key":"6972_CR37","doi-asserted-by":"publisher","first-page":"842","DOI":"10.1111\/jth.14001","volume":"16","author":"S Testa","year":"2018","unstructured":"Testa S, Paoletti O, Legnani C, Dellanoce C, Antonucci E, Cosmi B, et al. Low drug levels and thrombotic complications in high-risk atrial fibrillation patients treated with direct oral anticoagulants. J Thromb Haemost. 2018;16(5):842\u20138.","journal-title":"J Thromb Haemost"},{"issue":"7","key":"6972_CR38","doi-asserted-by":"publisher","first-page":"1064","DOI":"10.1111\/jth.14457","volume":"17","author":"S Testa","year":"2019","unstructured":"Testa S, Legnani C, Antonucci E, Paoletti O, Dellanoce C, Cosmi B, et al. Drug levels and bleeding complications in atrial fibrillation patients treated with direct oral anticoagulants. J Thromb Haemost. 2019;17(7):1064\u201372.","journal-title":"J Thromb Haemost"},{"issue":"8","key":"6972_CR39","doi-asserted-by":"publisher","first-page":"1008","DOI":"10.1055\/a-1450-8178","volume":"121","author":"J Douxfils","year":"2021","unstructured":"Douxfils J, Adcock DM, Bates SM, Favaloro EJ, Gouin-Thibault I, Guillermo C, et al. 2021 update of the international Council for standardization in haematology recommendations for laboratory measurement of direct oral anticoagulants. Thromb Haemost. 2021;121(8):1008\u201320.","journal-title":"Thromb Haemost"},{"key":"6972_CR40","unstructured":"Specialisten FM. Antitrombotisch beleid. 2021\u20132025.\u00a0https:\/\/richtlijnendatabase.nl\/richtlijn\/antitrombotisch_beleid\/startpagina_-_antitrombotisch_beleid.html."},{"key":"6972_CR41","doi-asserted-by":"publisher","first-page":"9511499","DOI":"10.1155\/2023\/9511499","volume":"2023","author":"T Ahuja","year":"2023","unstructured":"Ahuja T, Raco V, Bhardwaj S, Green D. To measure or not to measure: direct oral anticoagulant laboratory assay monitoring in clinical practice. Adv Hematol. 2023;2023:9511499.","journal-title":"Adv Hematol"}],"container-title":["BMC Geriatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12877-026-06972-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-06972-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12877-026-06972-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T12:33:48Z","timestamp":1774614828000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12877-026-06972-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,1,23]]},"references-count":41,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6972"],"URL":"https:\/\/doi.org\/10.1186\/s12877-026-06972-3","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7542541\/v1","asserted-by":"object"}]},"ISSN":["1471-2318"],"issn-type":[{"value":"1471-2318","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,1,23]]},"assertion":[{"value":"5 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 January 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 January 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"This study was conducted in accordance with the Declaration of Helsinki. The medical ethics committee (METC) of the MUMC\u2009+\u2009assessed the study and concluded that due to the nature of the study it does not fall under the scope of the Medical Research Involving Human Subjects Act (METC number 2024-0052).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Formal written informed consent was not required in accordance with applicable regulations, as completion of the survey was taken as implicit consent. Prior to the start of the questionnaire, respondents were informed about the intention to publish the data obtained from the completed questionnaires.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"418"}}